Follow-The-Filings

Security · featured owners

ORIC Oric Pharmaceuticals Inc.

COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.2%
  • $56M
  • 1 reduce 1 exit

Who owns this now

Largest portfolio weights among featured holders · max 0.2% (Andreas Halvorsen - Vikin...) · not free-float ownership

  1. Andreas Halvorsen reduce 0.16%

holders

sorted by value · long equity only · current book 2026 Q2 · exits show last held size · open a manager for their book

history
Andreas Halvorsen - Viking Global Investors 2026 Q2 0.16% Reduce −12.0% 5,126,762 $56M history
Nathan Fischel - Dafna Capital Management exited 2026 Q2 last 2026 Q1 0.22% Exit −0.22 pp 98,724 $945K history

1 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$100.7M -$127.85M -$129.47M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $212.6M $262.25M $288.47M
Total non-current assets * $39.41M $11.89M $120.42M
Total assets $252.01M $274.14M $408.89M
Total current liabilities $20.46M $24.85M $20.42M
Total non-current liabilities * $7.46M $6.17M $4.11M
Total equity $224.09M $243.12M $384.36M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$85.69M -$112.66M -$110.97M
Cash from investing -$43.4M $22.14M -$148.03M
Cash from financing $85.66M $126.55M $245.26M
Net change in cash -$43.43M $36.02M -$13.74M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders